Augmentation urethroplasty for female urethral stricture. Technique & short term outcome

Pandya S1, Mallikarjun C1, Bhavtej1

Research Type

Clinical

Abstract Category

Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 224
Prize Video, Prolapse, Urethroplasty, Transgender
Scientific Podium Video Session 14
Thursday 8th September 2022
17:42 - 17:51
Hall G1
Female Bladder Outlet Obstruction New Instrumentation
1. Asian Institute of Nephrology & Urology
In-Person
Presenter
Links

Abstract

Introduction
Female urethral strictures are frequently misdiagnosed. There is a paucity in literature regarding the ideal technique of urethroplasty in female urethral strictures.
Design
This is a prospective study of female patients with urethral stricture who underwent urethroplasty at our institute from January 2018 to February  2022. Patients with minimum follow-up of 6 months were included in the study. Female stricture disease was diagnosed based on the obstructive voiding symptoms, voiding cystourethrogram and urethroscopy. Female urethral stricture was defined as a urethral caliber <12 Fr on urethroscopy. We performed Anterior onlay buccal mucosal graft urethroplasty in all patients as described in the video. Patients were followed up with symptom scores, uroflometry and ultrasound for postvoid residual urine at 3rd month and 6th monthly thereafter. A successful outcome was defined as normal voiding without the need for any instrumentation to improve urinary flow rate.
Results
A total 24 female patients underwent urethroplasty with a mean age of 45±2.5 years. The mean stricture length was 2.5±0.5 cm. The mean operative time was 48±5 minutes. There were no peri-operative complications. Overall success rate was 91.6% with a median follow-up of 22.5 months One patient developed recurrent stricture. One patient had poor urinary flow due to hypotonic bladder with no anatomical obstruction in urethra.
Conclusion
Anterior onlay augmentation urethroplasty technique for female urethral strictures is feasible safe, with excellent short-term outcomes.
Disclosures
Funding None Clinical Trial No Subjects Human Ethics not Req'd it is aretrospective study. Helsinki Yes Informed Consent Yes
Citation

Continence 2S2 (2022) 100313
DOI: 10.1016/j.cont.2022.100313

20/11/2024 14:02:35